CINCINNATI--(BUSINESS WIRE)--Eccrine Systems, Inc., has been awarded a $750,000 SBIR Phase II contract by the United States Air Force, focused on real-time measurement of specific biomarkers in human sweat as an index of cognitive performance. The Phase II project will help enable commercial development of Eccrine’s innovative sweat sensing technology that was the subject of a preceding USAF SBIR Phase I research contract.
“We are very pleased to receive this award,” said George Raihala, Defense & Security Programs Director at Eccrine Systems, “It acknowledges the successful results we attained during the SBIR Phase I project and will accelerate development and commercialization of non-invasive wearable devices that will monitor cognitive status while warfighters are operating under thermally stressful conditions.”
The SBIR Phase II commercialization project commenced in November and will continue into late 2019.
About Eccrine Systems, Inc.
Eccrine Systems is a privately held company dedicated to improving human health, safety, and productivity through the innovation and development of advanced sweat sensing technologies. The Cincinnati-based company was founded in 2013 to commercialize technology and intellectual property that was exclusively licensed from the University of Cincinnati, and with the funding support of CincyTech and its network of local, regional and national investment sources. To learn more, please visit www.eccrine.com.
Trademarks
Eccrine Systems and the company logo image are registered trademarks of Eccrine Systems, Inc.
Safe Harbor Statement
Some of the statements made in this press release are forward-looking statements about Eccrine Systems, Inc. These forward-looking statements are based upon the company's current expectations and projections about future events and generally relate to the company’s plans, objectives and expectations for the development of its business. Although management believes that the plans and objectives reflected in or suggested by these forward-looking statements are reasonable, all forward-looking statements involve risks and uncertainties and actual future results may be materially different from the plans, objectives and expectations expressed in this press release.
DISTRIBUTION STATEMENT A. Approved for public release: distribution is unlimited. 88ABW Cleared 01/31/18; 88ABW-2018-0418.
